| Jun 11 2010 |
Phase II of the FDA’s Transparency Initiative: The Transparency Task Force Releases Draft Recommendations on FDA’s Public Disclosure Policies |
Foley Hoag LLP |
| Apr 12 2010 |
New U.S. Law Establishes Long Awaited Abbreviated Approval Pathway for Biosimilars |
Sterne, Kessler, Goldstein & Fox P.L.L.C. |
| Mar 24 2010 |
Personalized Medicine and Patentability: Important Considerations After Healthcare Reform |
Sterne, Kessler, Goldstein & Fox P.L.L.C. |
| Jan 27 2010 |
Soaring Patent Activity in Biofuel Technology Part II |
Lowndes, Drosdick, Doster, Kantor & Reed, P.A. |
| Jan 27 2010 |
Soaring Patent Activity in Biofuel Technology Part I |
Lowndes, Drosdick, Doster, Kantor & Reed, P.A. |
| Jan 1 2010 |
Generic Substitution and Biopharmaceuticals: Where Are All the Follow-on Biologics? And, How Much Money Will They Save? |
Carpenter Law Firm PC |
| Dec 31 2009 |
Preparing for Pandemic Flu |
Ryley Carlock & Applewhite, A Professional Corporation |
| Dec 18 2009 |
Medical Facilities Turn to Alternative Waste Disposal Options |
Dinsmore & Shohl LLP |
| Nov 10 2009 |
H1N1 - Is Your Business Ready? |
Dinsmore & Shohl LLP |
| Nov 1 2009 |
The Arrival of H1N1 Influenza: Legal Considerations and Practical Suggestions for Employers |
Davis Wright Tremaine LLP |
| Sep 30 2009 |
OTC Drug and Dietary Supplement Labeling: Adverse Event Reporting Information |
Sheppard, Mullin, Richter & Hampton LLP |
